An adenosine agonist, designated chemically as (R)-N-(2.3-dihydro-lH-inden-l-yl) adenosine or CI-947. was administered orally to 2 males and 2 female cynomolgus monkeys each at 5, 10, 20, and 50 mg/kg of body weight for 2 wk. One male and 1 female given 50 m g k g were euthanatized on days 10 and 8, respectively, because of poor clinical condition. Emesis was present at 10, 20, and 5 0 m a g . Decreased heart rate and QT prolongation were present at 5 0 mgkg. Extramural coronary arterial lesions consisting of medial necrosis with cellular debris and mixed inflammatory cell response in the intima, media, and adventitia were present in 1 male at 20 m g k g and 1 male at 50 mgkg at study termination. Similar arterial lesions were present in the small and large intestines and testis of the male at 50 m a g . Colonic mucosal erosions with mixed inflammatory cell infiltrates in the lamina propria were seen in this male and in all CI-947 treated females at 10. 20, and 5 0 mgkg. Myocardial degeneration and necrosis of myocardial fibers with mononuclear cell infiltrates in the interstitium were noted in the left ventricle of 1 female at 20 m a g and in all animals at 50 mag. Renal cortical tubular dilatation with increases in serum creatinine andor blood urea nitrogen were noted in a control female and animals at 10 and 50 mgkg. Plasma CI-947 concentration increased with increasing dose. Coronary vascular injury in the monkey was similar to the arterial lesion in C1-947-treated dogs and may relate to the pharmacologiclhemodynamic effects induced by CI-917. When compared with the dog, the monkey appears to be less sensitive to development of arteriopathy, as indicated by lower incidence, at similar systemic exposure levels. characterized by medial vacuolation, transmural necrosis, and perivascular accumulation of neutrophils was noted at 24 and 48 hr after a single oral dose of 5 mgkg body weight (1 3). This study in cynomolgus monkeys was conducted to provide comparative data on toxicity of CI-947 in nonrodent species. In this report, we describe the arterial lesions and other findings in monkeys given CI-947 for 2 wk. This is the first published information on xenobioticinduced arteriopathy in monkeys.
INTRODUCTION
Administration of various types of xenobiotics such as vasodilators (minoxidil, theobromine, hydrazine, and type I11 phosphodiesterase inhibitors) and adrenergic inotropicbut were not consistently affected by the time the study was terminated. Coronary menopathy and myocardial necrosis were Observed at doses. ArterioPathy was also noted . . in the-alimentary tract, kidneys, lymph nodes, amines (isoproterenol, norepinephrine, dopamine, and dobutamine) have been associated with arteriopathy in dogs (6-9, 11, 12, 17) . None of these compound have previously been reported to induce arterial changes in monkeys.
Adenosine plays an important role in the adjustment of coronary blood flow in response to the metabolic requirements of the heart (2, 5) . Adenosine and its analogs are potent vasodilators in heart, skeletal muscle, and brain. In addition, adenosine causes negative inotropic and chronotropic effects, with a depressant effect on the sinus and AV nodes (3, 16 ).
An adenosine agonist designated chemically as (R)-N-(2,3-dihydro-1H-inden-1-yl) adenosine (CI-947) was investigated as a potential antihypertensive agent. In a previous toxicity study in beagles at doses of 5, 10, and 20 mg/kg administered for 2 wk, clinical signs were observed at 10 and 20 m a g . Emesis, fecal changes (soft, mucoid, or red), hypoactivity and hypothermia, reduced food consumption, and emaciation were noted. Although heart rates were lower prior to dosing on days 7 and 14, heart rates were not affected after dosing. Blood pressure tended to be lower than pretest levels early in the study kg for 2 wk. An additional 2 male and 2 female monkeys received methylcellulose and served as a control group. Clinical Observations. Animals were observed for clinical signs. of toxicity or systemic effects. Food consumption was assessed daily. Monkeys were weighed prior to study start, once weekly, and at termination of the study. Clinical and ophthalmic examinations were performed pretest and during week 2. Electrocardiograms and heart rate measurements were evaluated predose and at 4 hr postdose on day 1, during week 2, and at termination of the study.
Clinical Luboratoy Analyses. Blood was collected from each monkey pretest and during week 2. Clinical pathology parameters evaluated in blood or serum included red blood cell count, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin concentration, mean corpuscular hemoglobin, platelet count, white blood cell count (total and differential), prothrombin and activated partial thromboplastin times, blood urea nitrogen (BUN), creatinine, sodium, potassium, chloride, calcium, alanine and aspartate aminotransferase, total bilirubin, alkaline phosphatase, fasting glucose, cholesterol, total protein, albumin, globulin, a-hydroxybutyrate dehydrogenase, lactate dehydrogenase, lactate dehydrogenase isoenzymes, and creatine phosphokinase. Urinalysis included specific gravity, pH, protein, bilirubin, glucose, occult blood, ketones, urobilinogen, and microscopic evaluation. Bone marrow was taken from all monkeys at termination of the study and evaluated by light microscopy.
Patliology. Monkeys were euthanatized with iv overdose of sodium pentobarbital. At necropsy, brain, pituitary, thymus, heart, liver, spleen, kidneys, adrenals, prostate, and gonads were weighed. Organ-to-body and organ-to-brain weight ratios were calculated. Complete necropsies were done on all monkeys. Samples of the following were fixed in 10% buffered formalin (except as noted), embedded in paraffin, sectioned at 4 pm, stained with hematoxylin and eosin (H&E), and examined microscopically: brain, spinal cord, pituitary, salivary gland, thyroid, trachea, lungs and bronchi, aorta, heart, thymus, esophagus, stomach, small intestine, large intestine, liver, gallbladder, pancreas, spleen, kidney, adrenal glands, urinary bladder, ovaries, testes, and epididymis (fixed in Zenker's fixative), uterus, vagina, prostate, mesenteric lymph node, eye (fixed in Zenker's fixative), skeletal muscle, skin, mammary gland, brachial nerve, bone, bone marrow, and gross lesions. In addition, 3 samples each from the circumflex branch, left interventricular, and right coronary arteries were also collected. Se--lected sections of heart, testis, and small and large intestine were also stained with phosphotungstic acid hematoxylin (PTAH) for the identification of fibrin.
Plasnin CI-947 Detenninatio~is. Plasma samples were evaluated for CI-947 concentrations pretest and on day 12 of study before dosing and approximately 2, 4, 8, and 24 hr postdose. One sample each was collected prior to euthanasia at 0.5 hr postdose from a moribund female at 50 mgkg on day 8 and at 22 hr postdose from a moribund male at 50 mgkg on day 10. To compare CI-947induced arteriopathy in monkeys and dogs, toxicokinetic data were acquired from a 2-wk CI-947 toxicity study in dogs. In that study, groups of 2 male and 2 female dogs were given CI-947 orally at daily doses of 5, 10, and 20 mgkg for 14 days. An additional 2 male and 2 female dogs received empty gelatin capsules and served as a control group. Plasma samples were taken pretestlpredose, and 2 and 6 hr postdose on days 1, 7, and 13 for determination of CI-947 concentrations.
RESULTS
drug-related results; if not reported, results were comparable to concurrent or historical controls or were not considered drug related.
Cliiiical Observations and Electrocardiograpliy
One male and 1 female monkey at 50 mg/kg were euthanatized in poor condition on days 10 and 8 of the study, respectively. Emesis, dehydration, and complete inappetence were present in both animals, and diarrhea was noted in the female prior to euthanasia. Emesis, primarily during the first 5 days of the study, was noted in treated animals at 10, 20, and 50 mgkg. There was no temporal pattern of occurrence of emesis after dosing. Blood tinged feces were noted in a female at 10 mgkg on day 14. At study termination, significant body weight losses (>lo% of pretest) were evident in the male and the female at 50 mg/kg, a male and a female at 20 mg/ kg, both females at 10 mgkg, and in a control female. Individual heart rates for animals at 50 mgkg were lower after treatment than pretest. In addition, QT prolongation was also evident posttreatment (Table I) .
Clinical Pathology
Mild increases in absolute neutrophil count were noted in a male (12.8 X 109/L) and the 2 females (14.6-16.9 BUN was also increased in a control female. In addition, sodium and chloride levels were decreased in females at 10 mgkg and 50 m g k g ( Table 11 ). The neutrophilia and the decreases in electrolytes were correlated with the colonic inflammatory changes noted in these animals histopathologically.
Pathology
Treatment-related changes were observed in the arteries, heart, colon, and kidney. The arterial lesions were noted in 1 male at 20 mg/kg and 1 male at 50 mg/kg euthanatized at study termination. No arterial lesions were noted in the moribund animals. The lesions involved extramural medium and small branches of the circumflex coronary artery in the male at 20 mgkg and the extramural branches of the right coronary artery of the male at 50 mgkg. In most affected coronary arteries, the lesions were characterized by minimal to mild necrosis and vacuolation of the media with nuclear debris and mixed inflammatory cell infiltrates in the adventitia. 1). In a few arteries, primarily in the male at 50 mgkg, the lesions were characterized by large localized areas of medial necrosis with marked mixed inflammatory cell infiltrates in the media and adventitia (Fig. 2 ). In addition, mononuclear cell inflammatory cells were seen in the intima (Fig. 2) of several arteries from the male at 50 mg/ kg. In this high dose male, arterial lesions were also noted in the submucosa of the large and small intestines and testis (tunical arteries). The arterial changes in the intestine ( Fig. 3) and testis were similar to those noted in the coronary arteries. Fibrin was identified by PTAH stain in the media of the affected arteries in the small and large intestine only.
At necropsy, the moribund male had focal hemorrhagic areas in the left ventricle and left and right auricles, which was confirmed histologically. Histopathological examinations showed myocardial lesions in the left ventricle, including the papillary muscle ( Fig. 4) , of one male and one female at 20 mgkg and all animals at 50 mg/kg (including the moribund animals). These lesions were characterized by minimal to mild multifocal areas of degeneration and necrosis of myocardial fibers with mono- At gross examination, multifocal areas of colonic mucosal erosion and congestion were observed in the all females at 10 and 50 mgkg. Histopathologically, colonic lesions were noted in 1 male at 50 mgkg and all treated females at 10, 20, and 50 mgkg. These lesions were characterized by multifocal mucosal erosions that differed in severity from mild to-marked with mixed inflammatory cell infiltrate in the' lamina propria (Fig. 5) . In some animals, the erosions were associated with multifocal areas of crypt hyperplasia andor dilatation. Colonic ulceration was noted in 1 female at 50 mgkg. In the male at 50 mgkg, the colonic arterial lesion appeared to have no relationship with the mild superficial colitis observed in the same section. No vascular changes were observed in the colon of the affected females.
Mild multifocal renal cortical tubular dilatation was observed in a control female, a female at 10 mgkg, and in the euthantized moribund male and female at 50 mg/ kg. These changes correlated with the increases in serum creatinine and/or BUN levels.
Plasina Drug Coitceiitratioiis
In general, plasma CI-947 concentration increased with increasing dose in monkeys and dogs (Table 111 ). Plasma concentration in the moribund male and female monkeys , at 50 mg&g (prior to euthanasia) was 11,300 ng/mg and 5,350 ng/ml, respectively. The monkey had much lower plasma levels of CI-947 than the dog at similar doses.
Peak plasma concentrations (C,,,) at 5 mgkg in dogs were comparable to those in the monkey at 20 mgkg. Adenosine agonists (including CI-947) can induce arteriopathy and myocardial necrosis in dogs (10, 13). Although arteriopathy was noted consistently in corona arteries in all treated dogs, arteriopathy was also present in other tissues (lymph node, stomach, adrenal gland, thyroid, ovary, ureter, and urinary bladder) (10, 13) . The coronary arteriopathy and the involvement of arteries in the intestine and testis of monkeys treated with CI-947 were similar to those induced in the dog by CI-947 and other vasoactive compounds (6-9, 11-13, 17) . No predilection for left or right coronary arteries and no atrial hemorrhage was present in monkeys with arteriopathy. In general, the arterial lesions in the monkey were similar to those reported in the dog, although medial fibrin deposition in the affected arteries, as usually seen in the dog, was not a prominent feature in the monkeys. This is the first report of drug-induced arteriopathy in primates. The absence of reports on drug-induced vasculitis in monkeys may be related to the limited number of studies of vasoactive compounds that have been conducted in monkeys or to the resistance of monkeys to development of arterial lesions. The resistance hypothesis is supported by presence of only 1 report (1) of spontaneous polyarteritis in a monkey. In contrast, dogs are particularly sensitive to development of spontaneous and drug-induced vasculitis. In this study, arteriopathy was noted in monkeys with C,,, levels of 25,000 ng/ml, and not all animals with these CI-947 concentrations developed arteriopathy. However, all dogs exposed to CI-947 developed arteriopathy irrespective of plasma CI-947 levels (2,783-17,233 ng/ml).
DISCUSSION
Drug-induced arteriopathy in dogs is generally considered a consequence of exaggerated pharmacologic or hemodynamic changes rather than direct cytotoxicity (6). Most of the compounds associated with arteriopathy in dogs induce vasodilation but differ in their structure and in their pharmacologic mode of action. Adenosine and adenosine agonists are potent coronary vasodilators (2) (3) (4) (5) . It has been hypothesized that the arterial lesions in dogs treated with CI-947 are due to vasodilation, which results in interendothelial gaps and the transudation of blood components into the wall and/or overdilatation of the smooth muscle with consequent smooth muscle cell necrosis (13) . Although the mechanisms of the arterial changes in the monkey are not known, vasodilation may play a major role in CI-947 induced arterial injury. There appears to be no clear relationship between coronary arteriopathy and the decrease in heart rate and the prolongation of the QT interval observed at 50 mg/kg. Arteriopathy was observed in male monkeys at 20 and 50 mg/ Abbreviation: NS = no sample obtained from moribund animal, \\hich was C, at day 12 for monkeys: mcan Z SD of C, at days 1.7, and 13 for dogs. hlonkeys with arteriopathy. All C1-947-treated dogs had artcriopathy.
-CI-917 concentration at 22 hr postdosc was 11,300 ng/rnl. CI-917 concentration at 0.5 hr postdose was 5,350 nglml. eurhmatized. kg, and the male at 20 mgkg had no changes in heart rate or QT interval. Heart rate changes may reflect the effect of CI-947 on the heart, which is similar to adenosine's negative inotropic and chronotropic effects on the atrial myocardium and depressant effects on the sinus and AV nodes (3, 16). In a study using a different adenosine agonist (lo), decreases in heart rate were reported in the treated monkeys, but coronary arteriopathy was observed only in the dogs and not in the monkeys.
The colonic lesions were probably directly or indirectly treatment related, with bacterial infection as a secondary condition. Although vascular compromise was considered an etiology for the colonic lesions, the absence of any vascular lesions in the females makes vascular etiology unlikely. These animals may have been carriers of enteropathogenic bacteria, and drug-related stress or colonic irritation resulted in flaring of dormant bacteria and the development of bacterial colitis.
The renal changes in treated animals may be related to CI-947 treatment because similar kidney changes have been observed in monkeys treated with another adenosine agonist (10) . Adenosine elicits renal vasoconstriction with secondary decrease in glomerular filtration rate (14, 15) . The renal changes in CI-947-treated animals may have been the result of electrolyte imbalance and CI-947. induced renal vasoconstriction. The etiology of the renal changes in the control female monkey is unknown.
Administration of adenosine agonist CI-947 to mon. keys for 2 wk caused coronary arteriopathy, charactenzed by medial necrosis with mixed inflammatory infiltrates in the intima, media, and adventitia. When compared with the dog, the monkey appears to be less sensitive to development of arteriopathy, as indicated by lower incidence at similar systemic exposure levels.
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